focu shift top-lin growth
focu shift top-lin growth today earn call management highlight
strong result reinforc compani abil sustain impress margin
achiev ep guidanc rais compris
out-performance quarter rais balanc year
remind guidanc exclud potenti benefit pyd total
compani well ahead origin margin
turnaround plan introduc last year management focus grow top-lin
compani via rfp opportun geograph expans expect also
key focal point compani upcom investor day may nyc
texa medicaid reprocur regard texa medicaid rfp rebid
continu expect award announc late june effect
award announc time effect
recal current bn total incumb revenu exposur
contract bn contract mn award may
implic broader medicaid consolid particularli
look expand medicaid footprint could still accomplish
marketplac margin exchang moh pre-tax net margin
industry-lead perhap sustain eye management
team inde expect exchang profit front-load guid
net margin year look ahead management acknowledg
margin exchang may declin due competit pressur
continu believ compani still grow marketplac profit dollar via
membership growth put togeth rais cash oper ep
ep new pt
base price-to-earnings higher ep maintain ew
quarterli annual ep usd
consensu number refinitiv receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
link barclay live interact chart
equal weight price target base
price-to-earnings ep reflect uncertainti
sustain margin exchang
lower visibl growth
upsid case reflect higher sustain
margin exchang addit cost save
upsid potenti greater membership growth
across medicaid medicar marketplac
downsid case reflect margin compress
exchang inabl harvest addit cost
save potenti membership loss
medicaid marketplac segment lead
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
oper ep reconcili
ep ca medicaid expans retroact revenu marketplac risk adjust marketplac csr loss sale restructur loss debt perform ep per amort intang oper ep per guidanc earn earn medicaid premium bnmedicar premium bnmarketplac premium bntotal premium bnpremium tax mninvest incom mntotal bnmedic care bnmedic care administr bng tax mndepreci mninterest expens expens mnincom incom mn mn mnnet mn mn mn mn mneffect tax weight averag mnnet incom per net incom per medicar mnmarketplac barclay
quarterli incom statement mn ep ep ep ep tax insur fee hif premium incom changepremium tax insur fee hif premium incom medic loss ratio gross insur py tax incom /expens addback intang ebitda margin ex inv expens exclud expens incom ebit ebit margin ex inv expens incom rate rate ex-hif minor interest/discontinu barclay
annual incom statement mn ep tax insur fee hif premium incom changepremium tax insur fee hif premium incom medic loss ratio gross insur py tax incom /expens addback intang ebitda margin ex inv expens exclud expens incom ebit ebit margin ex inv expens incom rate rate ex-hif minor interest/discontinu barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
procedur pleas
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
price sourc refinitiv last avail close price relev trade market unless anoth time sourc indic
barclay bank plc and/or affili lead manag co-lead manag publicli disclos offer secur issuer
 employe non-execut director barclay plc director issuer
cd barclay bank plc and/or affili market-mak debt secur issu issuer
ce barclay bank plc and/or affili market-mak equiti secur issu issuer
barclay bank plc and/or affili receiv compens invest bank servic issuer past month
 barclay bank plc and/or affili expect receiv intend seek compens invest bank servic issuer
within next month
fa barclay bank plc and/or affili benefici own class equiti secur issuer calcul accord
us regul
fb barclay bank plc and/or affili benefici own long posit class equiti secur issuer
calcul accord eu regul
fc barclay bank plc and/or affili benefici own short posit class equiti secur issuer
calcul accord eu regul
gd one analyst fundament credit coverag team member household financi interest debt
equiti secur issuer
ge one analyst fundament equiti coverag team member household financi interest debt
equiti secur issuer
 issuer benefici own class common equiti secur barclay plc
barclay bank plc and/or affili parti agreement issuer provis financi servic barclay bank plc and/or
affili
 barclay bank plc and/or affili liquid provid and/or trade regularli secur issuer and/or relat
 barclay bank plc and/or affili receiv non-invest bank relat compens includ compens brokerag
